BeiGene Seeks Historic Third Listing in Shanghai, Complementing US and HK
The 11-year-old money-losing biotech has filed for a listing on Shanghai’s STAR Market to raise more than $3 billion Key Takeaways: BeiGene will become the world's first stock to be…
RELATED ARTICLES
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG -
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
- Uni-Star under fire as its hit games enter twilight phase
-
ZG Group set to forge Hong Kong’s second De-SPAC listing
2572.HK
-
CATL leads new charge of Mainland-listed companies into Hong Kong
300750.SHE
-
Seyond may get stuck in slow-moving SPAC lane to Hong Kong listing
7855.HK
- Youlife chases SPAC listing after death of Hong Kong IPO
